In a very recent examine, we claimed the identification as well as the characterization of a completely new atypical opioid receptor with distinctive adverse regulatory Attributes toward opioid peptides.1 Our final results confirmed that ACKR3/CXCR7, hitherto often called an atypical scavenger receptor for chemokines CXCL12 and CXCL11, can also be